Triphenylamine flanked boron difluoride formazanate for NIR-II fluorescence imaging-guided photothermal therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Design of superior phototheranostic agents guided by Jablonski diagrams10.1039/D0CS00671H ↗
2. Photothermal nanofibres enable safe engineering of therapeutic cells10.1038/s41565-021-00976-3 ↗
3. Type I photosensitizers revitalizing photodynamic oncotherapy10.1002/smll.202006742 ↗
4. Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy10.1021/acsami.6b15505 ↗
5. An amphiphilic PEGylated peptide dendron-gemcitabine prodrug-based nanoagent for cancer therapy10.1002/marc.202100111 ↗
6. In vivo imaging-guided photothermal/photoacoustic synergistic therapy with bioorthogonal metabolic glycoengineering-activated tumor targeting nanoparticles(article)10.1021/acsnano.7b03226 ↗
7. Stimuli-responsive nanobubbles for biomedical applications10.1039/C9CS00839J ↗
8. One-pot growth of triangular SnS nanopyramids for photoacoustic imaging and photothermal ablation of tumors10.1039/C9NJ03045J ↗
9. Mitochondria-Targeting MoS2-based nanoagents for enhanced NIR-II photothermal-chemodynamic synergistic oncotherapy10.1021/acsami.1c18311 ↗
10. Cu2MoS4 nanozyme with NIR-II light enhanced catalytic activity for efficient eradication of multidrug-resistant bacteria10.1002/smll.202001099 ↗
11. Infection microenvironment-activated nanoparticles for NIR-II photoacoustic imaging-guided photothermal/chemodynamic synergistic anti-infective therapy10.1016/j.biomaterials.2021.120918 ↗
12. Near infrared light responsive hybrid nanoparticles for synergistic therapy10.1016/j.biomaterials.2016.05.023 ↗
13. Phthalocyanines as contrast agents for photothermal therapy
14. Small molecular NIR-II fluorophores for cancer phototheranostics
15. Chen D, Dai H, Wang W, Cai Y, Mou X, Zou J, et al. Proton-driven transformable 1O2-nanotrap for dark and hypoxia tolerant photodynamic therapy. Adv Sci.n/a(n/a):2200128.
16. Promoted intramolecular photoinduced-electron transfer for multi-mode imaging-guided cancer photothermal therapy10.1007/s12598-021-01795-0 ↗
17. Evaluation of visible NIR-I and NIR-II light penetration for photoacoustic imaging in rat organs10.1364/OE.389714 ↗
18. Polymer-based therapeutic nanoagents for photothermal-enhanced combination cancer therapy10.1002/sstr.202100110 ↗
19. Recent progress in fluorescent probes for bacteria10.1039/D0CS01340D ↗
20. Optical nano-agents in the second near-infrared window for biomedical applications10.1039/C8CS00494C ↗
21. NIR-II organic nanotheranostics for precision oncotherapy10.1002/smll.202102646 ↗
22. Fluorescent cadmium chalcogenide nanoclusters in ubiquitin
23. Recent advances on activatable NIR‐II fluorescence probes for biomedical imaging10.1002/adom.201900917 ↗
24. Fluorescence imaging in vivo at wavelengths beyond 1500 nm10.1002/anie.201507473 ↗
25. More severe toxicity of gold nanoparticles with rougher surface in mouse hippocampal neurons10.1007/s11771-021-4844-1 ↗
26. Tm3+-Sensitized NIR-II fluorescent nanocrystals for in vivo information storage and decoding10.1002/anie.201903536 ↗
27. Ultrasmall semiconducting polymer dots with rapid clearance for second near-infrared photoacoustic imaging and photothermal cancer therapy10.1002/adfm.201909673 ↗
28. High performance one-for-all phototheranostics: NIR-II fluorescence imaging guided mitochondria-targeting phototherapy with a single-dose injection and 808 nm laser irradiation10.1016/j.biomaterials.2019.119671 ↗
29. Boron difluoride formazanate dye for high-efficiency NIR-II fluorescence imaging-guided cancer photothermal therapy10.1016/j.cclet.2021.11.079 ↗
30. Specific small‐molecule NIR‐II fluorescence imaging of osteosarcoma and lung metastasis10.1002/adhm.201901224 ↗
31. Thienothiadiazole-based NIR-II dyes with D–A–D structure for NIR-II fluorescence imaging systems10.1021/acsabm.1c00274 ↗
32. A design strategy for D–A conjugated polymers for NIR-II fluorescence imaging10.1039/D1PY00470K ↗
33. Band gap engineering in acceptor-donor-acceptor boron difluoride formazanates10.1021/acs.joc.1c01416 ↗
34. Diketopyrrolopyrrole‐derived organic small molecular dyes for tumor phototheranostics10.1016/j.cclet.2021.10.054 ↗
35. Aza-BODIPY-based nanomedicines in cancer phototheranostics10.1021/acsami.0c05021 ↗
36. Organic fluorescent nanoparticles with NIR-II emission for bioimaging and therapy
37. Near-infrared-II (NIR-II) bioimaging via off-peak NIR-I fluorescence emission10.7150/thno.27995 ↗
38. NIR-II AIEgens: a win-win integration towards bioapplications10.1002/anie.202005899 ↗
39. Rational design of a multifunctional molecular dye for dual-modal NIR-II/photoacoustic imaging and photothermal therapy10.1039/C9SC03504D ↗
40. Small structures bring big things: performance control of hollow multishelled structures10.1002/sstr.202000041 ↗
41. Near-infrared photoluminescence and electrochemiluminescence from a remarkably simple boron difluoride formazanate dye10.1002/anie.201811144 ↗
42. A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues10.1038/s41467-018-03505-4 ↗
43. D-A-D structured selenadiazolesbenzothiadiazole-based near-infrared dye for enhanced photoacoustic imaging and photothermal cancer therapy10.1016/j.cclet.2021.02.017 ↗
44. S/Se-embedded acenaphthylene-imide-containing polycyclic heteroaromatic hydrocarbon10.1016/j.cclet.2021.06.072 ↗
45. All‐in‐One phototheranostics: single laser triggers NIR‐II fluorescence/photoacoustic imaging guided photothermal/photodynamic/chemo combination therapy
46. Enlarging the reservoir: high absorption coefficient dyes enable synergetic near infrared-II fluorescence imaging and near infrared-I photothermal therapy10.1002/adfm.202102213 ↗
47. Recent progress of Acenaphthylene-imide-fused polycyclic aromatic hydrocarbons: synthesis and application10.1016/j.dyepig.2020.108877 ↗
48. Facile access to deep red/near-infrared emissive AIEgens for efficient non-doped OLEDs(Article)10.1039/C8SC01377B ↗
49. Core-shell microparticles: from rational engineering to diverse applications10.1016/j.cis.2021.102568 ↗
50. Polycyclic naphthalenediimide-based nanoparticles for NIR-II fluorescence imaging guided phototherapy10.1007/s11426-020-9723-9 ↗
51. Near-infrared II dye-protein complex for biomedical imaging and imaging-guided photothermal therapy10.1002/adhm.201800589 ↗
52. Single-molecular near-infrared-II theranostic systems: ultrastable Aggregation-induced emission nanoparticles for long-term tracing and efficient photothermal therapy10.1021/acsnano.8b05937 ↗
53. Albumin tailoring fluorescence and photothermal conversion effect of near-infrared-II fluorophore with aggregation-induced emission characteristics10.1038/s41467-019-10056-9 ↗
54. Molecular engineering of D–A–D conjugated small molecule nanoparticles for high performance NIR-II photothermal therapy10.1039/C9MH00660E ↗
55. Near-infrared aza-BODIPY dyes through molecular surgery for enhanced photothermal and photodynamic antibacterial therapy10.1007/s40242-021-1190-7 ↗
56. A highly-efficient type I photosensitizer with robust vascular-disruption activity for hypoxic-and-metastatic tumor specific photodynamic therapy10.1002/smll.202001059 ↗